Polygenic scores and their applications in kidney disease

2024-9-13

The pathogenesis of IgA nephropathy and implications for treatment

2024-9-4

A novel mechanism of sodium and fluid retention in liver disease

2024-9-3

Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups

2024-9-2

Towards an effective obstetric nephrology care: the Mansoura experience

2024-8-29

Amino acid metabolism in kidney health and disease

2024-8-28

Microglial activation in CKD-associated cognitive decline

2024-8-27

NOX2 dampens TLR7 to protect the kidneys in SLE

2024-8-27

The roles of hyaluronan in kidney development, physiology and disease

2024-8-27

A focus on kidney ageing

2024-8-20

Advances in uromodulin biology and potential clinical applications

2024-8-19

Improving the quality of pharmacoepidemiological studies using the target trial emulation framework

2024-8-13

From improbable to possible: pregnancy with advanced chronic kidney disease

2024-8-7

Lymphocytes and innate immune cells in acute kidney injury and repair

2024-8-2

Making advance care planning easier for adults with kidney disease and their clinicians

2024-8-1

Drug repurposing for glomerular diseases: an underutilized resource

2024-7-31

Anti-nephrin autoantibodies: a paradigm shift in podocytopathies

2024-7-30

The GLP-1 receptor agonist revolution comes to nephrology

2024-7-29

Tertiary lymphoid organs contribute to kidney allograft rejection

2024-7-29

Obesity promotes tumour growth by boosting PD1 levels on macrophages

2024-7-26

Ketogenic diet benefits in critically ill patients with sepsis

2024-7-24

CD38 — a new target in renal immune disease

2024-7-23

Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors

2024-7-22

The impact of population ageing on the burden of chronic kidney disease

2024-7-18

Pathological mechanisms of kidney disease in ageing

2024-7-18

Deep learning applications in digital pathology

2024-7-16

Treatment of chronic kidney disease in older populations

2024-7-8

Application of spatial-omics to the classification of kidney biopsy samples in transplantation

2024-7-4

The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

2024-7-3

A pre-specified analysis of the SELECT trial suggests a kidney benefit of semaglutide in patients without diabetes

2024-7-2

Regulation of kidney fibrosis by ILC3s via a gut–kidney axis

2024-7-2

Avenciguat reduces albuminuria in patients with chronic kidney disease

2024-7-2

Natural killer cell-mediated innate microvascular rejection

2024-6-19

Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes

2024-6-18

Unlocking the benefits of transplantation with kidneys from older donors

2024-6-18

Healthy ageing and the kidney — lessons from centenarians

2024-6-17

Gene regulatory networks in disease and ageing

2024-6-12

Chronic kidney disease in American Indians and Alaska Natives

2024-6-7

Home monitoring of patients with chronic kidney disease

2024-6-4

Cystatin C and the misdiagnosis of CKD in older adults

2024-6-3

Mutational signatures of ccRCC vary between geographical regions

2024-5-31

VHL loss attracts immune cells to tumours

2024-5-31

Remodelling by macula densa cells

2024-5-30

Sleep disorders in chronic kidney disease

2024-5-24

Kidney health within the broader non-communicable disease agenda

2024-5-17

Podocyte-targeted therapies — progress and future directions

2024-5-9

Spatial transcriptomics in health and disease

2024-5-8

A patient perspective on kidney disease in the public health agenda

2024-5-7

Role of the gut microbiota in the pathogenesis of IgA nephropathy

2024-4-29

Progression and outcomes of rare kidney diseases

2024-4-26